Bernard Ross, CEO of Sky Medical Technology, outlines how the NHS can ease pressures in chronic wound care management.
Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer This study used a retrospective single-group, pretest–post-test design. Data representing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback